We now have two FDA-approved disease-modifying treatments for Alzheimer's disease, and hundreds of clinical trials are ...

The disease afflicts nearly seven million Americans, about one in every nine people over the age of 65, making it a leading ...

The gene mutation was isolated in a family in northern Italy where under half of the relations developed the disease. View on ...

Arctic therapeutics raises funding from EIC Fund, Kaldbakur, and Sanos Group to advance its dementia treatment, AT-001, and acne drug, AT-004. The company aims to transform the treatment landscape for ...

Icelandic drug discovery and development company Arctic Therapeutics (ATx) today announced the successful closing of a €26.5 million oversubscribed Series A financing from a broad syndicate of ...

Alzheimer's disease is likely caused by stalled protein processing in the brain, according to a new study.

Italian researchers have discovered a new gene that causes Alzheimer's Disease, according to a new study out Sunday. The ...

Lactylation is a reversible, covalent, post-translational modification of proteins. It happens exclusively on lysine residues, where it influences protein structure, stability, localization, and ...

Alzheimer's disease Diagnostic market Insights: Rising prevalence of Alzheimer's and focus on early diagnosis drive growth.

Living in a family where there is genetic risk for dementia significantly affects choices about having children and how to ...

Understanding dementia and Alzheimer’s disease is essential for maintaining a proactive approach to our well-being.

New research suggests that the risk for developing dementia is significantly higher than previously estimated, and the burden ...